526 reports of this reaction
15.5% of all TIOCONAZOLE reports
#1 most reported adverse reaction
VULVOVAGINAL BURNING SENSATION is the #1 most commonly reported adverse reaction for TIOCONAZOLE, manufactured by Insight Pharmaceuticals LLC. There are 526 FDA adverse event reports linking TIOCONAZOLE to VULVOVAGINAL BURNING SENSATION. This represents approximately 15.5% of all 3,387 adverse event reports for this drug.
Patients taking TIOCONAZOLE who experience vulvovaginal burning sensation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
VULVOVAGINAL BURNING SENSATION is a frequently reported adverse event for TIOCONAZOLE, accounting for a significant proportion of all reports.
In addition to vulvovaginal burning sensation, the following adverse reactions have been reported for TIOCONAZOLE:
The following drugs have also been linked to vulvovaginal burning sensation in FDA adverse event reports:
VULVOVAGINAL BURNING SENSATION has been reported as an adverse event in 526 FDA reports for TIOCONAZOLE. This does not prove causation, but indicates an association observed in post-market surveillance data.
VULVOVAGINAL BURNING SENSATION accounts for approximately 15.5% of all adverse event reports for TIOCONAZOLE, making it one of the most commonly reported side effect.
If you experience vulvovaginal burning sensation while taking TIOCONAZOLE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.